US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.82

+0.34801.01%

Volume:14.09K

Turnover:489.40K

Market Cap:96.80M

PE:- -

High:34.92

Open:34.52

Low:34.42

Close:34.47

52wk High:36.84

52wk Low:23.42

Shares:2.78M

Float Shares:2.78M

Volume Ratio:0.80

T/O Rate:0.51%

Dividend:0.26

Dividend Rate:0.74%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sichuan Biokin Pharmaceutical to Engage Investors at Star Market Innovation Drug Sector Earnings Briefing

Innovative Drug Indices Rally, ETFs See Inflows, CXO and Research Services Show Strong Momentum

A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

AI Integration Becomes Essential for Biopharma's Future, Says Henlius CEO

Amgen EVP, CFO Thomas J.W. Dittrich Files Initial Beneficial Ownership Statement

Amgen is Maintained at Equal-Weight by Wells Fargo

Alphamab Oncology Reduces Float with Fresh Share Buyback Valued at HK$492,430

Traditional Chinese Medicine Firm Secures Regulatory Approval for New Depression Treatment

Patient Dies in CAR-T Trial, Director Tells Reporter to "Get Lost," IPO Filed Just 15 Days Earlier — Family Demands Answers

China Galaxy Securities Forecasts High-Growth Prospects in Innovative Drug Sector Driven by Commercialization and Out-Licensing Deals

Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst

Vortex Energy to Launch Ground Gravity Survey at Robinsons River Salt Project

Political and General News Events from September 3

Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer

Navigating the Investment Landscape Amid the Innovative Drug Surge

CMS Secures NMPA Nod for Ruxolitinib Cream's Expanded Use in Atopic Dermatitis

Apichope's Gout Drug Candidate Meets Primary Goal in Late-Stage China Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/IBBQ/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.82,"timestamp":1789416000000,"preClose":34.472,"halted":0,"volume":14094,"delay":0,"changeRate":0.01009514968670222,"floatShares":2780001,"shares":2780001,"eps":0,"marketStatus":"Pre-Mkt","change":0.348,"latestTime":"09-15 06:33:34 EDT","open":34.52,"high":34.92,"low":34.42,"amount":489401.81775,"amplitude":0.014505,"askPrice":55.71,"askSize":200,"bidPrice":32.86,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":34.82,"sharesOutstanding":2520001,"nav":34.43989,"aum":95742928.63989,"dividendRate":0.007412,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.82,"preClose":34.82,"latestTime":"19:30 EDT","volume":36,"amount":1244.0123,"timestamp":1789428600873,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8014967633025524,"impliedVol":0.1149,"impliedVolPercentile":0.492},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2780001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8014967633025524,"shares":2780001,"dividePrice":0.2581,"high":34.92,"amplitude":0.014505,"preClose":34.472,"low":34.42,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.82,"eps":0,"divideRate":0.007412,"volume":14094,"delay":0,"ttmEps":0,"open":34.52,"prevYearClose":28.3962,"prevWeekClose":34.472,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":36.05,"twentyDayClose":33.8122,"sixtyDayClose":29.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1167267027","title":"Sichuan Biokin Pharmaceutical to Engage Investors at Star Market Innovation Drug Sector Earnings Briefing","url":"https://stock-news.laohu8.com/highlight/detail?id=1167267027","media":"Deep News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167267027?lang=en_us&edition=fundamental","pubTime":"2026-09-06 20:40","pubTimestamp":1788698452,"startTime":"0","endTime":"0","summary":"On September 6, Sichuan Biokin Pharmaceutical Co., Ltd. (688506) issued a notice confirming its participation in the Star Market’s collective earnings briefing for the innovation drug sector covering...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","IBBQ","06978","LNGR","KSTR","MEDX","688506","BK0239","91194","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122138400","title":"Innovative Drug Indices Rally, ETFs See Inflows, CXO and Research Services Show Strong Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1122138400","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122138400?lang=en_us&edition=fundamental","pubTime":"2026-09-06 10:40","pubTimestamp":1788662438,"startTime":"0","endTime":"0","summary":"Over the past three months, three major innovative drug indices—the Shanghai Stock Exchange STAR Innovative Drug Index, the CSI Innovative Drug Industry Index, and the Hang Seng HK Stock Connect...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IBBQ","BK4550","BK1161","WX","BK4588","CXO","BK1574","MEDX","LNGR","159992","06978","FDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365115","title":"A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665365115?lang=en_us&edition=fundamental","pubTime":"2026-09-06 02:01","pubTimestamp":1788631260,"startTime":"0","endTime":"0","summary":"In a consequential week for Novartis, the Swiss drug maker released results for two of three trials that Wall Street has watched for in the second half of the year.Novartis saw U.S.-listed shares soar","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125154935.USD","LU0868494617.USD","BK4599","BK4007","LU2242646821.SGD","MEDX","BK4559","LU1983299246.USD","LU2236285917.USD","PBE","IYF","BIB","LU1162221912.USD","LU2360032135.SGD","IBB","LU0106831901.USD","LU0128525689.USD","LU2242652126.USD","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU2462157665.USD","NVS","BK4581","IBBQ","LU0130102774.USD","SG9999001440.SGD","TBXU","LU2456880835.USD","TFNS","BK4566","LU1057294990.SGD","BBH","AMGN","LU0314106906.USD","LU1061106388.HKD","LU1244550221.USD","LU2112291526.USD","LU0211331839.USD","LU0889565916.HKD","LU0052756011.USD","PJP","LU0980610538.SGD","BK4533","LU0320765489.SGD","LU0070302665.USD","BK4139","FTXO","LU1074936037.SGD","PPH","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665682593","title":"Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2665682593","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665682593?lang=en_us&edition=fundamental","pubTime":"2026-09-05 17:01","pubTimestamp":1788598891,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($ACRS) ), ( ($EYPT) ), ( ($VRTX) ), ( ($GTLB) ) and ( ($NB) ). Here is a breakdown of their recent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/aclaris-eyepoint-vertex-gitlab-niocorp-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/aclaris-eyepoint-vertex-gitlab-niocorp-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","IE00B19Z3B42.SGD","LU1035775433.USD","LU2462157665.USD","PBE","IE00BFTCPJ56.SGD","EYPT","LU1559883803.SGD","LU0417517546.SGD","LU0234570918.USD","LU1093756325.SGD","BBH","GTLB","LU0757428866.USD","VRTX","IBBQ","LU0289739699.SGD","VERX","TBXU","LU0079474960.USD","IE0002141913.USD","IE0002270589.USD","LU2456880835.USD","SG9999013999.USD","IE00B4R5TH58.HKD","IE00B19Z9P08.USD","BIB","IBB","LU2236285917.USD","SG9999001176.SGD","BK4613","LU2362541513.USD","LU1674673428.USD","LU1093756168.USD","IE0009355771.USD","LU1778281490.HKD","IE00B894F039.SGD","LU1069344957.HKD","BK4097","LU2089984988.USD","LU2468319806.SGD","BK4533","IE00B2B36J28.USD","IDNA","IE00B19Z9Z06.USD","GNMX","IE00BJJMRZ35.SGD","BK4607","IE00BZ9MQY76.HKD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158783895","title":"AI Integration Becomes Essential for Biopharma's Future, Says Henlius CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1158783895","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158783895?lang=en_us&edition=fundamental","pubTime":"2026-09-05 14:20","pubTimestamp":1788589217,"startTime":"0","endTime":"0","summary":"At the 2026 Yabuli Forum Summer Annual Meeting, held from September 4-6 in Chengdu, Sichuan, Zhu Jun, CEO of HENLIUS, stated that the primary mission of the healthcare industry is to help people live...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306685.HKD","HK0000306701.USD","CHAT","IBBQ","HK0000165453.HKD","01477","QTOC","BK1191","BBP","02696","MRNX","AIPO","AGIX","HK0000320264.USD","ARTY","VTHR","MRNY","BK1161","BK1574","HK0000320223.HKD","03069"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665352504","title":"Amgen EVP, CFO Thomas J.W. Dittrich Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2665352504","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665352504?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:53","pubTimestamp":1788562416,"startTime":"0","endTime":"0","summary":"Amgen EVP, CFO Thomas J.W. Dittrich files initial beneficial ownership statementAmgen EVP and CFO Thomas J.W. Dittrich reported 16,860 common shares in an initial SEC Form 3 filing.Disclaimer:This new","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL6SPhM6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00B4R5TH58.HKD","BK4585","IE0002141913.USD","BIB","BK4534","LU0058720904.USD","LU1057294990.SGD","AMGN","BK4139","LU2242652126.USD","IE00BJT1NW94.SGD","LU1571399168.USD","IE00BJJMRZ35.SGD","IBB","LU0289739699.SGD","LU0109394709.USD","LU1061106388.HKD","TBXU","PBE","LU1023059063.AUD","LU1983299246.USD","LU2468319806.SGD","BK4566","BK4581","LU0320765992.SGD","LU0889565916.HKD","LU2089984988.USD","LU2242646821.SGD","IE00B2B36J28.USD","BBH","IE00BFTCPJ56.SGD","BK4599","IBBQ","BK4588","LU2112291526.USD","PJP","SG9999001440.SGD","LU0868494617.USD","BK4533","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665235617","title":"Amgen is Maintained at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2665235617","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665235617?lang=en_us&edition=fundamental","pubTime":"2026-09-05 02:47","pubTimestamp":1788547620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMGN/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYF","LU1069347547.HKD","LU1074936037.SGD","IE0002270589.USD","LU0708994859.HKD","LU0310799852.SGD","LU0868494617.USD","BK4534","LU1814569148.SGD","LU0742534661.SGD","LU0128525929.USD","LU0640476718.USD","BK4559","IE0009355771.USD","LU0154236417.USD","PGF","FTXO","LU0787776722.HKD","PJP","IE00BFTCPJ56.SGD","LU1061106388.HKD","TFNS","LU0175139822.USD","LU0942090050.USD","IE00BJT1NW94.SGD","LU0971096721.USD","BBH","LU2361044949.HKD","TBXU","LU0106831901.USD","BK4581","LU2361044865.SGD","LU0130102774.USD","IBB","IBBQ","LU0889565916.HKD","BK4533","LU0417517546.SGD","LU0162691827.USD","BK4582","LU0130517989.USD","LU1035773651.USD","IE00B4R5TH58.HKD","PBE","KBWB","BIB","LU1894683348.USD","AMGN","LU1571399168.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179349089","title":"Alphamab Oncology Reduces Float with Fresh Share Buyback Valued at HK$492,430","url":"https://stock-news.laohu8.com/highlight/detail?id=1179349089","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179349089?lang=en_us&edition=fundamental","pubTime":"2026-09-04 22:20","pubTimestamp":1788531633,"startTime":"0","endTime":"0","summary":"Alphamab Oncology (stock code: 09966) has executed a share buyback on the Hong Kong Stock Exchange, purchasing a total of 56,000 ordinary shares during the trading session on September 4, 2026....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","IBBQ","CNAV","EWH","MRNY","03069","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103371342","title":"Traditional Chinese Medicine Firm Secures Regulatory Approval for New Depression Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1103371342","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103371342?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:54","pubTimestamp":1788526459,"startTime":"0","endTime":"0","summary":"TRAD CHI MED (00570) has announced that its subsidiary, Guizhou Tongjitang Pharmaceutical Co., Ltd., has received official market authorization from the National Medical Products Administration...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","MEDX","00570","BK1515","BK1191","IBBQ","IPOS","06978","LNGR","BK1606","159992","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152466212","title":"Patient Dies in CAR-T Trial, Director Tells Reporter to \"Get Lost,\" IPO Filed Just 15 Days Earlier — Family Demands Answers","url":"https://stock-news.laohu8.com/highlight/detail?id=1152466212","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152466212?lang=en_us&edition=fundamental","pubTime":"2026-09-04 18:51","pubTimestamp":1788519063,"startTime":"0","endTime":"0","summary":"\"Get lost, this is annoying!\" That was the response a reporter received on September 2 when calling Li Mouxin, a director of Immuncell Biotechnology Co., Ltd. (hereinafter \"Immuncell\"), regarding the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","IBBQ","BMED","IPOS","PSYK","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125606398","title":"China Galaxy Securities Forecasts High-Growth Prospects in Innovative Drug Sector Driven by Commercialization and Out-Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=1125606398","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125606398?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:42","pubTimestamp":1788511349,"startTime":"0","endTime":"0","summary":" China Galaxy Securities has released a research report indicating that after a significant pullback in the pharmaceutical sector during the first half of the year, valuations for both innovative and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","601881","BK1564","BK1147","BK1574","06978","BK0188","BK0276","159992","161027","BK1161","LNGR","06881","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664980438","title":"Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2664980438","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664980438?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:47","pubTimestamp":1788468476,"startTime":"0","endTime":"0","summary":"Regeneron director Kathryn Guarini disposes of 400 common shares worth $340,000Regeneron director Kathryn Guarini sold 400 shares on Sep. 2 at USD 850 per share.She exercised stock options for 400 sha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL9s8sKq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU0109394709.USD","LU2089984988.USD","LU1974910355.USD","LU1917777945.USD","BK4139","LU2362541273.HKD","BK4585","LU0823434740.USD","LU2023250504.SGD","LU0320765992.SGD","LU2362540622.SGD","LU0882574055.USD","LU2237438978.USD","LU2106854487.HKD","LU0889565916.HKD","BK4588","LU0053666078.USD","LU0289739699.SGD","REGN","IBBQ","LU0058720904.USD","IBB","LU2362541513.USD","LU0823434583.USD","LU0823416689.USD","LU2468319806.SGD","BBH","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664012018","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2664012018","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664012018?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:35","pubTimestamp":1788467700,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 1.08% to $151.22 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.06% to 7,747.71 and the Dow Jones Industrial Average  rising 1.18% to 53,686.11.Gilead Sciences Inc. closed 3.86% short of its 52-week high of $157.29, which the company reached on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  rose 1.17% to $278.43, Pfizer Inc.  fell 0.72% to $28.81, and Abbott Laboratories  fell 1.52% to $108.79.Trading volume  remained 2.3 million below its 50-day average volume of 6.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 3, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015986.USD","BK4566","LU0320765992.SGD","LU0965509101.SGD","IBBQ","LU0965509283.SGD","LU0109394709.USD","SG9999015952.SGD","LU1934455863.HKD","LU0058720904.USD","LU1585245621.USD","LU0889565916.HKD","SG9999015978.USD","LU0122379950.USD","LU2089984988.USD","BK4583","BBH","BK4585","LU0289739699.SGD","LU1839511570.USD","BK4568","LU1674673691.USD","IE00B19Z3581.USD","IBB","LU1057294990.SGD","LU1037948541.HKD","LU1061106388.HKD","SG9999015945.SGD","IE00B19Z3B42.SGD","LU0859254822.USD","GILD","LU1778281490.HKD","LU0823416689.USD","BK4139","IE00BZ1G4Q59.USD","LU1934455277.USD","LU2357627491.SGD","BK4532","TBXU","LU1066053197.SGD","MEDI","BMED","LU0114720955.EUR","LU2112291526.USD","LU1571399168.USD","LU2324357040.USD","LU0965508806.USD","LU1430594728.SGD","LU0882574055.USD","LU1023059063.AUD","BK4550","LU2468319806.SGD","IE00BKVL7J92.USD","TMED","LU1037948897.HKD","LU0965509010.AUD","BK4578","LU0861579265.USD","LU2087621335.USD","LU1066051498.USD","BK4588","LU1674673428.USD","LU1934455194.USD","IE00BSNM7G36.USD","IE0002270589.USD","LU0234570918.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664805389","title":"Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2664805389","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664805389?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:30","pubTimestamp":1788453034,"startTime":"0","endTime":"0","summary":"Gilead Sciences ($GILD) announced an update on their ongoing clinical study. Gilead Partner Study Marks Milestone in First-Line Stomach Cancer Ther...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gileads-arcus-backed-cancer-trial-reaches-completion-setting-up-a-key-immuno-oncology-catalyst?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gileads-arcus-backed-cancer-trial-reaches-completion-setting-up-a-key-immuno-oncology-catalyst?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0122379950.USD","LU1061106388.HKD","LU0823416689.USD","LU1839511570.USD","IBBQ","SG9999015952.SGD","BK4566","BK4588","LU2089984988.USD","BBH","LU1778281490.HKD","LU0058720904.USD","SG9999015945.SGD","BMED","BK4532","LU0965508806.USD","LU0861579265.USD","BK4583","LU0965509283.SGD","TMED","LU1057294990.SGD","LU2468319806.SGD","LU0289739699.SGD","LU0965509101.SGD","LU1430594728.SGD","BIB","IE00B7SZLL34.SGD","GILD","IE00B3T34201.USD","LU1037948541.HKD","LU1066053197.SGD","TBXU","LU1674673428.USD","LU1934455277.USD","IBB","LU1066051498.USD","LU1934455194.USD","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","MEDI","SG9999015978.USD","IE00B19Z3581.USD","LU2112291526.USD","IE00BKVL7J92.USD","LU1585245621.USD","LU1571399168.USD","BK4139","LU2324357040.USD","LU0882574055.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803700","title":"Vortex Energy to Launch Ground Gravity Survey at Robinsons River Salt Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803700?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:04","pubTimestamp":1788451496,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has issued an update. Vortex Energy Corp. plans to launch a targeted ground gravity survey at its wholly owned ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-to-launch-ground-gravity-survey-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-to-launch-ground-gravity-survey-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1430594728.SGD","LU1674673691.USD","IE00B2B36J28.USD","LU1035775433.USD","LU2236285917.USD","LU2362541273.HKD","SG9999001176.SGD","VRTX","IE00BZ9MQY76.HKD","IE00B19Z9P08.USD","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0289739699.SGD","LU0823416689.USD","LU2362540622.SGD","BBH","LU0079474960.USD","BK4139","LU0889565916.HKD","IDNA","GNMX","IE00B19Z3B42.SGD","SG9999013999.USD","IE00B19Z9Z06.USD","IE00B19Z3581.USD","BK4585","IE00BJT1NW94.SGD","PBE","LU0320765992.SGD","IE00BJJMRZ35.SGD","BK4532","IE0002270589.USD","LU2237438978.USD","LU0234570918.USD","IBBQ","LU0058720904.USD","SGXZ57979304.SGD","IE0009355771.USD","LU2362541513.USD","LU1069344957.HKD","LU1093756168.USD","TBXU","LU0109394709.USD","BIB","IBB","LU2324357040.USD","IE0002141913.USD","BK4588","IE00B4R5TH58.HKD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664741898","title":"Political and General News Events from September 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2664741898","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664741898?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:26","pubTimestamp":1788438361,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from September 3Sept 3 (Reuters)-For other diaries, please see:Political and General NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4N44V0YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4599","LU1983299246.USD","IBBQ","LU0889565916.HKD","BK4533","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4139","LU1023059063.AUD","BK4588","LU2468319806.SGD","IBB","LU0868494617.USD","LU0289739699.SGD","AMGN","BK4566","LU1571399168.USD","LU0122379950.USD","BK4585","IE0009355771.USD","LU1057294990.SGD","LU2242646821.SGD","IE00B4R5TH58.HKD","SG9999001440.SGD","TBXU","LU0058720904.USD","LU2089984988.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","LU2242652126.USD","PJP","LU1061106388.HKD","BIB","BK4534","IE0002141913.USD","PBE","IE00BJT1NW94.SGD","LU2112291526.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664487978","title":"Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664487978","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664487978?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:32","pubTimestamp":1788435147,"startTime":"0","endTime":"0","summary":"Eikon Therapeutics names Ching-Pin Chang as chief scientific officerEikon Therapeutics named Ching-Pin “CP” Chang executive vice president, chief scientific officer.Chang joins from Bristol Myers Squi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL9l9Cns:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU0267386448.USD","LU1585245621.USD","IE00BQXX3D17.EUR","IBB","MEDI","LU1934455194.USD","NDAQ","GILD","IE00BQXX3C00.GBP","LU1718418525.SGD","FTXH","LU2133065610.SGD","LU1023059063.AUD","BK4550","LU1236620834.HKD","LU2087621335.USD","LU2360032135.SGD","LU1093756325.SGD","BMY","LU2242652126.USD","BCDF","IHE","IE00BKPKM429.USD","LU2095319765.USD","TBXU","LU0306807586.USD","LU1983299246.USD","LU0109394709.USD","LU0965509010.AUD","LU2242646821.SGD","LU2125154778.USD","BMED","LU0114720955.EUR","BK4585","EIKN","IE00BN0W2V16.EUR","LU1291159041.SGD","LU0122379950.USD","IE00B64PRP62.GBP","LU1057294990.SGD","LU2089984988.USD","BIB","IBBQ","LU0321505868.SGD","LU0859254822.USD","LU1839511570.USD","SG9999014021.USD","TMED","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135667303","title":"Navigating the Investment Landscape Amid the Innovative Drug Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1135667303","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135667303?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:20","pubTimestamp":1788430837,"startTime":"0","endTime":"0","summary":"As the innovative drug sector gains momentum, investors are keenly eyeing opportunities that align with this upward trend. The recent formation of a MACD golden cross signal, a key technical...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK1574","06978","159992","BK1161","LNGR","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176808711","title":"CMS Secures NMPA Nod for Ruxolitinib Cream's Expanded Use in Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=1176808711","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176808711?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:04","pubTimestamp":1788429862,"startTime":"0","endTime":"0","summary":"CMS (00867) has announced that its subsidiary, Demei Pharma, obtained approval from China's National Medical Products Administration (NMPA) on September 2, 2026, for the New Drug Application (NDA) of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4132","IBBQ","00867","SG9999015952.SGD","06978","BK1593","SG9999015945.SGD","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","AD","BK1191","159992","MEDX","LU2488822045.USD","SG9999004220.SGD","IPOS","LNGR","BK1161","SG9999015978.USD","IE00BYV24P56.USD","SG9999015986.USD","IE00BVYPNQ40.USD","IE00BMCWC346.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148282007","title":"Apichope's Gout Drug Candidate Meets Primary Goal in Late-Stage China Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1148282007","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148282007?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:50","pubTimestamp":1788429022,"startTime":"0","endTime":"0","summary":"Apichope Pharmaceutical Group Co.,Ltd. (300723.SZ) has announced that its wholly-owned subsidiary, Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd., recently obtained top-line data from a Phase...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","MEDX","IBBQ","LNGR","BK0239","300723","159992","BK1574","06978"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}